Cocrystal Pharma Inc (COCP) Dividend History

$1.88 $0.01

Dividend Score
Dividend Yield

Annual Payment

Payout Ratio
Dividend Increases
0 yrs

Price Chart

Key Metrics

Sector Healthcare
Industry Biotechnology
Avg daily volume 32,536
Market cap 19,025,000
Beta 1.2
Trailing 12 Month EPS -2.21
Next Earnings Date
Ex-dividend date
P/E ratio 0

Company Description

cocrystal (otcqb:cocp) is a pharmaceutical company seeking to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. cocrystal employs unique technologies and nobel prize winning expertise to create first- and best-in-class antiviral drugs. these technologies, including our nucleoside chemistry expertise and market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. the company has identified promising, preclinical stage antiviral compounds for the unmet medical needs including hepatitis, influenza and norovirus infections. cocrystal has previously received strategic investments from teva pharmaceuticals, opko health (opk), dr. raymond schinazi, brace pharmaceutical, llc, and the frost group.

Dividend Payments

Forward Yield
Forward Payment

Trailing Yield
Trailing Payment

Last Increase
> 10 Years Ago
Last Cut
> 10 Years Ago

5 Year Average Yield
Vs Current Yield

5 Year Div Growth Rate
Payment Frequency

Historical Dividend Payments